Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
Actual shortage: | 249 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
36 (14%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-TADALAFIL | 10MG | TABLET | Resolved | 2021-06-03 | 2021-06-10 | 140378 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2021-06-17 | 2021-07-22 | 141122 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2021-06-17 | 2021-07-15 | 141128 |
TEVA-CYCLOBENZAPRINE | 10MG | TABLET | Resolved | 2021-07-08 | 2021-12-08 | 142195 |
TEVA-CYCLOBENZAPRINE | 10MG | TABLET | Resolved | 2021-07-29 | 2021-08-05 | 143259 |
TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2021-09-09 | 2022-03-26 | 145449 |
TEVA-BISOPROLOL | 10MG | TABLET | Resolved | 2021-09-23 | 2021-11-11 | 146101 |
ACT AMLODIPINE | 10MG | TABLET | Resolved | 2021-09-30 | 2021-10-07 | 146443 |
TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2021-09-30 | 2021-11-11 | 146449 |
TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2021-10-07 | 2021-11-11 | 146847 |
TEVA-CITALOPRAM | 10MG | TABLET | Resolved | 2021-11-18 | 2022-01-07 | 149609 |
TEVA-CITALOPRAM | 10MG | TABLET | Resolved | 2022-01-07 | 2022-01-13 | 152411 |
TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2022-01-07 | 2022-08-19 | 152417 |
TEVA-FLUOXETINE | 10MG | CAPSULE | Actual shortage | 2022-01-27 | 2022-09-22 | 153718 |
TEVA-LEFLUNOMIDE | 10MG | TABLET | Resolved | 2022-02-10 | 2022-05-19 | 154723 |
TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2022-02-17 | 2022-03-24 | 155152 |
TEVA-FLUOXETINE | 10MG | CAPSULE | Resolved | 2022-02-17 | 2022-02-17 | 155162 |
OCTREOTIDE FOR INJECTABLE SUSPENSION | 10MG | POWDER FOR SUSPENSION, EXTENDED-RELEASE KIT | Resolved | 2022-03-04 | 2022-03-24 | 156070 |
TEVA-TAMOXIFEN | 10MG | TABLET | Resolved | 2022-03-24 | 2022-12-02 | 157256 |
ACT ESCITALOPRAM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-03-31 | 2022-06-17 | 157637 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Discontinued | 2020-01-21 | 2020-01-21 | 103788 |
TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |